Company Filing History:
10 out of 110 
4 out of 2,890 
2 out of 16 Years Active: 2004-2020
Title: The Innovative Mind of Suzanne M. de la Monte: Pioneering Alzheimer's Research and Cancer Diagnosis
Introduction: Suzanne M. de la Monte, an accomplished inventor based in East Greenwich, RI, has made significant strides in the fields of neuroscience and oncology. With a portfolio of eight patents, her innovative research focuses on crucial advancements in the diagnosis and treatment of complex diseases, including Alzheimer's Disease and malignant neoplasms.
Latest Patents: Among her latest inventions, de la Monte has developed a groundbreaking method for increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition. This invention not only includes a non-transgenic model of Alzheimer's Disease but also outlines methods for inducing prolonged in vivo gene expression in mammals and inhibiting neuronal cell death associated with Alzheimer's. Additionally, she has made notable advancements in the diagnosis and treatment of malignant neoplasms through her invention that utilizes a specific antibody to diagnose cancer in mammals by binding to human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide, alongside methods to inhibit HAAH for therapeutic purposes.
Career Highlights: Suzanne de la Monte currently works at Rhode Island Hospital, where she continues her impactful research. Her work has garnered recognition within the scientific community, and she has been instrumental in advancing our understanding of both Alzheimer's Disease and cancer, providing hope for better diagnostic tools and treatment options.
Collaborations: Throughout her career, de la Monte has collaborated with esteemed colleagues such as Jack Raymond Wands and Nedim Ince. Their combined expertise has fostered an environment of innovation and progress at Rhode Island Hospital, contributing to the success of their joint research endeavors.
Conclusion: Suzanne M. de la Monte stands as a beacon of innovation in medical research. With her extensive experience and commitment to addressing critical health issues, her contributions hold the promise of transforming the landscape of disease diagnosis and treatment, ultimately aiming for better patient outcomes in the fight against Alzheimer's and cancer.